MentionFox
Home › Who owns › Caris Life Sciences, Inc.
Owners, funding and legal record

Who owns Caris Life Sciences, Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in Caris Life Sciences, Inc.

MentionFox check on Caris Life Sciences, Inc.: no red flags found in 15 sources (checked 6 November 2026). mentionfox.com/c/who-owns/caris-life-sciences

Check Caris Life Sciences, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Caris Life Sciences, Inc.?

Caris Life Sciences, Inc. is a publicly traded company (Nasdaq: CAI). The most recent 5%+ ownership report names Fidelity (FMR) holding 13.4% (Schedule 13G/A, filed 2026-11-05).

As of November 6, 2026, Caris Life Sciences, Inc. is a publicly traded company (Nasdaq: CAI); its largest reported holder is Fidelity (FMR), with 13.4% on Schedule 13G/A of November 5, 2026. The largest insider holding is Caris Halbert, L.P., a director and 10% owner, with 125,485,341 shares (43.8% of shares outstanding), per Form 4 of June 23, 2025 (Schedule 13G/A, November 5, 2026).

FMR LLC also filed stake reports on 761 other companies ↓

Is this your company?

About to sign with, pay or invest in Caris Life Sciences, Inc.? See the free Snapshot first.

Watch Caris Life Sciences, Inc.

Free to see. No signup.

Is Caris Life Sciences, Inc. a real, registered company?

Before you sign or pay

Who are Caris Life Sciences, Inc.'s owners and officers?

Caris Life Sciences, Inc.: incorporated in Texas; business address in Irving, Texas; industry Services-Medical Laboratories (Schedule 13G/A, 2026-11-05).

ReportHolderShare
Schedule 13G/A, 2026-11-05Fmr LLC13.4%
Schedule 13G/A, 2026-08-12J H Whitney Vi L P4%
Schedule 13G/A, 2026-08-07Alan Waxman2.6%
Schedule 13G/A, 2026-05-12J H Whitney Vi L P6.5%
Schedule 13G/A, 2026-05-12Alan Waxman5.1%
Schedule 13G/A, 2026-04-07Fmr LLC10.8%
Schedule 13G/A, 2026-02-13Alan Waxman6.9%
Schedule 13G, 2026-02-05Fmr LLC5%
Schedule 13G, 2025-08-14J H Whitney Vi LP7.3%
Schedule 13G, 2025-08-13David D. Halbert44.1%
Schedule 13G, 2025-07-28Alan Waxman8.8%

Questions about who owns Caris Life Sciences, Inc.

Who owns Caris Life Sciences, Inc.?

On this page, 3 holders' latest ownership filings report 5% or more of Caris Life Sciences, Inc.: David D. Halbert (44.1%, Schedule 13G, filed 2025-08-13), Fmr LLC (13.4%, Schedule 13G/A, filed 2026-11-05) and J H Whitney Vi LP (7.3%, Schedule 13G, filed 2025-08-14).

Who are the largest shareholders of Caris Life Sciences, Inc.?

By the share each holder's latest filing reports, the largest holders of Caris Life Sciences, Inc. on this page are David D. Halbert (44.1%), Fmr LLC (13.4%) and J H Whitney Vi LP (7.3%).

When did David D. Halbert buy into Caris Life Sciences, Inc.?

The filings give report dates, not purchase dates. The earliest filing from David D. Halbert on this page is the Schedule 13G, filed 2025-08-13, reporting 44.1%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Caris Life Sciences, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Caris Life Sciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Caris Life Sciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    20 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Caris Life Sciences, Inc. shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 286,784,504 as of 2026-11-02, from the company's latest SEC cover page.

How much has Caris Life Sciences, Inc. raised?

Latest IPO step: Caris Life Sciences, Inc. filed its final IPO prospectus, ticker CAI (424B4, 2025-06-20).

IPO filings: 424B4, 2025-06-20, S-1/A, 2025-06-16, S-1/A, 2025-06-09, S-1, 2025-05-23; ticker CAI on Nasdaq Global Select Market.

Keep reading

More on Caris Life Sciences, Inc. and the records around it.

Caris Life Sciences, Inc. elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/caris-life-sciences
Last updated 2026-11-06
Who owns Caris Life Sciences? Publicly traded (Nasdaq: CAI). MentionFox, 2026-11-06. https://mentionfox.com/who-owns/caris-life-sciences